UA83437C2 - Способ получения фармацевтической композиции, содержащей венлафаксин, и композиция - Google Patents

Способ получения фармацевтической композиции, содержащей венлафаксин, и композиция Download PDF

Info

Publication number
UA83437C2
UA83437C2 UAA200700846A UAA200700846A UA83437C2 UA 83437 C2 UA83437 C2 UA 83437C2 UA A200700846 A UAA200700846 A UA A200700846A UA A200700846 A UAA200700846 A UA A200700846A UA 83437 C2 UA83437 C2 UA 83437C2
Authority
UA
Ukraine
Prior art keywords
aza
aai
miyiza
iai
iaye
Prior art date
Application number
UAA200700846A
Other languages
English (en)
Ukrainian (uk)
Inventor
Роберт Писек
Закель Мойца Сегула
Original Assignee
Крка, Товарна Здравил, Д.Д., Ново Место
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Крка, Товарна Здравил, Д.Д., Ново Место filed Critical Крка, Товарна Здравил, Д.Д., Ново Место
Publication of UA83437C2 publication Critical patent/UA83437C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5026Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Изобретение относится к фармацевтике, в частности к способу получения фармацевтической композиции, который включает следующие стадии: (1) получение дисперсии венлафаксина или соли венлафаксина в растворителе, в каком венлафаксин или соль венлафаксина имеют растворимость менее 25 г/литр при комнатной температуре; (2) превращение дисперсии, полученной на стадии (1), в форму частиц; (3) покрытие частиц, полученных на стадии (2), слоем полимера, который обеспечивает замедленное высвобождение действующего вещества. Изобретение относится также к композиции, полученной этим способом.
UAA200700846A 2004-07-28 2005-07-27 Способ получения фармацевтической композиции, содержащей венлафаксин, и композиция UA83437C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004036641A DE102004036641A1 (de) 2004-07-28 2004-07-28 Verzögert freisetzende pharmazeutische Zusammensetzung, die Venlafaxin enthält
PCT/EP2005/008149 WO2006010605A2 (en) 2004-07-28 2005-07-27 Sustained release pharmaceutical particulate composition comprising venlafaxine

Publications (1)

Publication Number Publication Date
UA83437C2 true UA83437C2 (ru) 2008-07-10

Family

ID=35106687

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200700846A UA83437C2 (ru) 2004-07-28 2005-07-27 Способ получения фармацевтической композиции, содержащей венлафаксин, и композиция

Country Status (16)

Country Link
EP (1) EP1778193B1 (ru)
AT (1) ATE381925T1 (ru)
CY (1) CY1107187T1 (ru)
DE (2) DE102004036641A1 (ru)
DK (1) DK1778193T3 (ru)
EA (1) EA009957B1 (ru)
ES (1) ES2299061T3 (ru)
HR (1) HRP20080007T3 (ru)
NO (1) NO20071139L (ru)
PL (1) PL1778193T3 (ru)
PT (1) PT1778193E (ru)
RS (1) RS50572B (ru)
SI (1) SI1778193T1 (ru)
UA (1) UA83437C2 (ru)
WO (1) WO2006010605A2 (ru)
ZA (1) ZA200701554B (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10722458B2 (en) * 2011-12-02 2020-07-28 Pegasus Laboratories, Inc. Amphipathic lipid-based sustained release compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL146462A (en) * 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
WO2003055475A1 (en) * 2002-01-03 2003-07-10 Lek Pharmaceutical And Chemical Company D.D. Controlled release pharmaceutical formulation containing venlafaxine
AU2003236947A1 (en) * 2002-06-07 2003-12-22 Ranbaxy Laboratories Limited Modified release, multiple unit drug delivery systems
WO2004047718A2 (en) * 2002-11-28 2004-06-10 Themis Laboratories Private Limited Process for manufacturing sustained release microbeads containing venlafaxine hci

Also Published As

Publication number Publication date
ATE381925T1 (de) 2008-01-15
EA200700159A1 (ru) 2007-06-29
DE602005004033D1 (de) 2008-02-07
WO2006010605A3 (en) 2006-09-21
DE602005004033T2 (de) 2009-01-02
EA009957B1 (ru) 2008-04-28
ES2299061T3 (es) 2008-05-16
RS50572B (sr) 2010-05-07
WO2006010605A2 (en) 2006-02-02
CY1107187T1 (el) 2012-10-24
NO20071139L (no) 2007-02-28
DE102004036641A1 (de) 2006-03-23
ZA200701554B (en) 2008-05-28
EP1778193B1 (en) 2007-12-26
DK1778193T3 (da) 2008-02-04
PT1778193E (pt) 2008-03-10
HRP20080007T3 (en) 2008-01-31
SI1778193T1 (sl) 2008-06-30
EP1778193A2 (en) 2007-05-02
PL1778193T3 (pl) 2008-05-30

Similar Documents

Publication Publication Date Title
UA83437C2 (ru) Способ получения фармацевтической композиции, содержащей венлафаксин, и композиция
CN108276820A (zh) 一种抗菌涂层剂及其制备方法以及一种抗菌涂层
Smart et al. The effect of Concord vineyard microclimate on yield. II. The interrelations between microclimate and yield expression
Hage Histochemistry and fine structure of bronchial carcinoid tumours
CN115300451A (zh) 一种负载有机纳米药物的抑菌创面凝胶的制备方法及应用
US20040001884A1 (en) Pharmaceutical tablet coating composition
Zacchini et al. Effect of photoperiod on some stomatal characteristics of in vitro cultured fruit tree shoots
CN107190234B (zh) 一种表面注银的TiN/Ag纳米多层膜及其制备方法与应用
Braun et al. New species and new records of biotrophic micromycetes from Australia, Fiji, New Zealand and Thailand
CN115385747A (zh) 一种长效型抗病增产叶面肥
CN109221274A (zh) 一种苹果树杀虫剂及其制备方法
Dubois et al. The direct regeneration of adventitious buds on leaf explants of glasshouse-grown cut rose cultivars
CN104886054A (zh) 一种茶蚜性诱剂制备方法及应用
CN108207977B (zh) 一种气候斑防治组合物及其制剂和应用
SG11201403396SA (en) Homogeneous hipims coating method
CN109089881B (zh) 一种耐寒天竺桂的不定芽诱导及增殖和植株再生方法
Choi et al. Effect of pretreatments on optimal harvesting stage and harvesting stages of cut roses bred in Korea
USPP31475P3 (en) Chinese redbud plant named ‘Chongyang’
CN1070542A (zh) 种子包衣剂
CN216314204U (zh) 一种乡村园林盆栽种植架
KR102358665B1 (ko) 카테콜기가 도입된 접착성 폴리에틸렌글리콜, 이의 제조방법 및 이의 용도
CN207322135U (zh) 树木冬季保温布
CN1729813A (zh) 兰花云雾茶及其制作工艺
CN117044727A (zh) 一种绿篱小苗专用除草剂及制备方法
CN118319944A (zh) 铈-锌抗菌材料的新应用